PM360

NOVEMBER 29, 2022

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. But that’s just the beginning.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

PM360

NOVEMBER 27, 2023

For example, insights from healthcare providers (HCPs) might be filtered through a medical science liaison’s interpretations, leading to gaps in the captured requirements. However, these roles are not immune to biases or misinterpretations, which can result in overlooked end-user requirements.

Engineering 115

Engineering Medical science Healthcare Provider Management 115

Medgadget

MARCH 2, 2023

This leads to substantial damage to healthy tissues and too often results in poor outcomes. The FDA looked at the data, saw it promising, and asked for a small feasibility study in the U.S. We hope to see Alpha TAU presenting its technology at Biomed Israel , the leading international Life Science and HealthTech conference in Israel.

Manufacturing 82

Manufacturing Leads Patients Medicine 82

Medgadget

FEBRUARY 17, 2023

Thanks to kind support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below), we met with Ronan Castro, the CEO of Human Xtensions at the company’s offices in Netanya, Israel. More info can be found at the Biomed Israel website.

Physicians 80

Physicians Engineering Leads Side effects 80

PM360

DECEMBER 20, 2024

When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. Regional Account Manager, and Shaun Terry, Sr.

Physicians 52

Physicians Marketing Competition Management 52

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. Biologics represent an increasingly large part of the pharmaceutical industry.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

European Pharmaceutical Review

DECEMBER 28, 2023

We received encouraging feedback from the US Food and Drug Administration (FDA) on the trial design and potential for accelerated approval. In addition, we have received Fast Track designation by the FDA in September 2023 highlighting the impact this combination treatment can have for patients. later acquired by Eli Lilly and Company.

Food and Drug Administration 84

Food and Drug Administration Patients Safety Medical science 84